NCT Number,Study Title,Study URL,Acronym,Study Status,Brief Summary,Study Results,Conditions,Interventions,Primary Outcome Measures,Secondary Outcome Measures,Other Outcome Measures,Sponsor,Collaborators,Sex,Age,Phases,Enrollment,Funder Type,Study Type,Study Design,Other IDs,Start Date,Primary Completion Date,Completion Date,First Posted,Results First Posted,Last Update Posted,Locations,Study Documents
NCT00180908,Comparison of High-Dose Methotrexate (HDM) Plus Doxorubicin to HDM Plus Etoposide-Ifosfamide in Osteosarcoma Children,https://clinicaltrials.gov/study/NCT00180908,,COMPLETED,The purpose of this study is to compare two preoperative chemotherapy regimens based on high-dose methotrexate courses given alternately either with doxorubicin or with etoposide-ifosfamide.,NO,Osteosarcoma|Localised High Grade Osteosarcoma of the Limbs,"DRUG: Etoposide, Ifosfamide, Methotrexate|DRUG: Doxorubicin, Methotrexate",Good histological response (5% or less viable cells) after preoperative chemotherapy,"Event-free survival,|Overall survival,|Toxicity.",,"Gustave Roussy, Cancer Campus, Grand Paris",,ALL,"CHILD, ADULT",PHASE3,226,OTHER,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,OS94|CSET-94-300,1994-06,,,2005-09-16,,2005-09-16,"Institut Gustave-Roussy, Villejuif, 94805, France",
